Login

CADENCE PHARMACEUTICALS INC 3 SEC Filings

Filed On Filing
15 Aug 2013 Form 3: Debuono Laureen, Director

Holds 0 shares of No shares are beneficially owned

15 Mar 2013 Form 3: Newman Stephen L, Director

Holds 0 shares of No shares are beneficially owned

06 Sep 2012 Form 3: Lloyd-Smith Malcolm, SVP, Reg Affairs, Qual & Clin

Holds 6,332 shares of Common Stock

17 Jan 2012 Form 3: Kamdar Kim P., 10% owner

Holds 27,500 shares of Common Stock

29 Mar 2010 Form 3: Eagle Michael L, Director

Holds 0 shares of No shares are beneficially owned

25 Jun 2009 Form 3: Byrd Scott A., SVP, Chief Commercial Officer

Holds 0 shares of No securities are beneficially owned

26 Feb 2009 Form 3: Frazier Healthcare VI, L.p., 10% owner and 2 others

Holds 3,128,258 shares of Common Stock

20 Feb 2009 Form 3: Dp Vii Associates Lp, 10% owner

Holds 46,634 shares of Common Stock

20 Feb 2009 Form 3: Domain Parters Vii L P, 10% owner

Holds 2,734,040 shares of Common Stock

28 Aug 2008 Form 3: Rich Todd W, Director

Holds 0 shares of No securities are beneficially owned

22 Feb 2008 Form 3: Frazier Healthcare V, Lp, 10% owner and 2 others

Holds 4,372,659 shares of Common Stock

19 Apr 2007 Form 3: Aker Hazel M, SVP, GC & Secretary
24 Oct 2006 Form 3: ProQuest Investments III, L.p., 10% owner and 4 others

Holds 12,500 shares of Common Stock

24 Oct 2006 Form 3: Halak Brian K, 10% owner

Holds 27,500 shares of Common Stock

24 Oct 2006 Form 3: Vitullo Nicole, 10% owner

Holds 27,500 shares of Common Stock

24 Oct 2006 Form 3: More Robert J, 10% owner

Holds 27,500 shares of Common Stock

24 Oct 2006 Form 3: Schoemaker Kathleen K, 10% owner

Holds 27,500 shares of Common Stock

24 Oct 2006 Form 3: Treu Jesse I, 10% owner

Holds 27,500 shares of Common Stock

24 Oct 2006 Form 3: Dovey Brian H, 10% owner

Holds 27,500 shares of Common Stock

24 Oct 2006 Form 3: Blair James C, Director

Holds 27,500 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support